UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Current use of CAR T cells to treat multiple myeloma

Hematology, 2023-12, Vol.2023 (1), p.340

2023

Volltextzugriff (PDF)

Aiming for the cure in myeloma: Putting our best foot forward

Blood reviews, 2023-11, Vol.62, p.101116-101116, Article 101116

2023

Volltextzugriff (PDF)

The Transition-State Structure for Human MAT2A from Isotope Effects

Journal of the American Chemical Society, 2017-10, Vol.139 (39), p.13754-13760

2017

Volltextzugriff (PDF)

Transition state analogue of MTAP extends lifespan of APCMin/+ mice

Scientific reports, 2021-04, Vol.11 (1), p.1-11, Article 8844

2021

Volltextzugriff (PDF)

Kinetic Isotope Effects and Transition State Structure for Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase from Plasmodium falciparum

Biochemistry (Easton), 2017-12, Vol.56 (48), p.6368-6376

2017

Volltextzugriff (PDF)

Minimal Residual Disease in Multiple Myeloma—Current Approaches and Future Clinical Implications

Hemato, 2022-09, Vol.3 (3), p.454-465

2022

Volltextzugriff (PDF)

Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase

Journal of medicinal chemistry, 2019-04, Vol.62 (7), p.3286-3296

2019

Volltextzugriff (PDF)

Continuous Fluorescence Assays for Reactions Involving Adenine

Analytical chemistry (Washington), 2016-12, Vol.88 (23), p.11860-11867

2016

Volltextzugriff (PDF)

Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5′-Methylthioadenosine Phosphorylase

ACS chemical biology, 2017-02, Vol.12 (2), p.464-473

2017

Volltextzugriff (PDF)

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

Blood advances, 2024-04, Vol.8 (7), p.1600-1611

2024

Volltextzugriff (PDF)

Microwave spectra, structure, and dynamics of the weakly bound complex, N2 CO2

The Journal of chemical physics, 2010-12, Vol.133 (24), p.244303-244303

2010

Volltextzugriff (PDF)

Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies

Blood advances, 2024-06, Vol.8 (12), p.3246-3253

2024

Volltextzugriff (PDF)

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Blood advances, 2024-06, Vol.8 (12), p.3038-3044

2024

Volltextzugriff (PDF)

P962: COMMERCIAL TECLISTAMAB IN ANTI‐BCMA THERAPY EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS: THE MSKCC EXPERIENCE

HemaSphere, 2023-08, Vol.7 (S3), p.e81198bb-n/a

2023

Volltextzugriff (PDF)

The Effects of Low‐Level Laser Light Exposure on Sperm Motion Characteristics and DNA Damage

Journal of andrology, 2012-05, Vol.33 (3), p.469-473

2012

Volltextzugriff (PDF)

Abstract 18: Doubled lifespan in APCMin/+ mice by targeting MTAP

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.18-18

2019

Volltextzugriff (PDF)

Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8049-8049

2023

Volltextzugriff (PDF)

P-486 Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S307-S308

2023

Volltextzugriff (PDF)

OA-03 Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S2-S2

2023

Volltextzugriff (PDF)

P-013 Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S40-S40

2023

Volltextzugriff (PDF)

Transition state analogue of MTAP extends lifespan of APC Min/+ mice

Scientific reports, 2021-04, Vol.11 (1), p.8844

2021

Volltextzugriff (PDF)

Enzymes and Transition State Structures Relating to SAM Metabolism

Firestone, Ross

2017

Volltextzugriff (PDF)

Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?

Reproductive biology and endocrinology, 2013-02, Vol.11 (1), p.12-12

2013

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(36)

Publikationsform

Sprache

Englisch
(41)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(21)
Life Sciences & Biomedicine
(17)
Humans
(10)
Hematology
(6)
Animals
(5)
Biochemistry & Molecular Biology
(5)
Kinetics
(4)
Female
(3)
Purine-Nucleoside Phosphorylase - Metabolism
(3)
Rats
(3)
Actors
(2)
Binding Sites
(2)
Biochemistry
(2)
Biological And Medical Sciences
(2)
Catalysis
(2)
Ccaat-Enhancer-Binding Proteins
(2)
Cell Biology
(2)
Chemistry
(2)
Dexamethasone - Pharmacology
(2)
Endocrinology & Metabolism
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current use of CAR T cells to treat multiple myeloma

Aiming for the cure in myeloma: Putting our best foot forward

The Transition-State Structure for Human MAT2A from Isotope Effects

Transition state analogue of MTAP extends lifespan of APCMin/+ mice

Kinetic Isotope Effects and Transition State Structure for Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase from Plasmodium falciparum

Minimal Residual Disease in Multiple Myeloma—Current Approaches and Future Clinical Implications

Selective Inhibitors of Helicobacter pylori Methylthioadenosine Nucleosidase and Human Methylthioadenosine Phosphorylase

Continuous Fluorescence Assays for Reactions Involving Adenine

Heat Capacity Changes for Transition-State Analogue Binding and Catalysis with Human 5′-Methylthioadenosine Phosphorylase

CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

Microwave spectra, structure, and dynamics of the weakly bound complex, N2 CO2

Unscheduled health care interactions in patients with multiple myeloma receiving T-cell redirection therapies

Patterns of CRS with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

P962: COMMERCIAL TECLISTAMAB IN ANTI‐BCMA THERAPY EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS: THE MSKCC EXPERIENCE

The Effects of Low‐Level Laser Light Exposure on Sperm Motion Characteristics and DNA Damage

Abstract 18: Doubled lifespan in APCMin/+ mice by targeting MTAP

Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies

P-486 Clinical significance of baseline body mass index and its trajectory during triplet induction therapy in newly diagnosed multiple myeloma

OA-03 Bispecific T-cell engager response is driven by pre-treatment CD8+ effector memory cells and inhibited by TIGIT+ Tregs in relapsed/refractory multiple myeloma

P-013 Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

Transition state analogue of MTAP extends lifespan of APC Min/+ mice

Enzymes and Transition State Structures Relating to SAM Metabolism

Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies

Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy

Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?

Aktive Filter

Suchergebnisse filtern